These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 14624662)

  • 21. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
    Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
    Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Starting or changing therapy - a prospective study exploring antiretroviral decision-making.
    Fehr JS; Nicca D; Sendi P; Wolf E; Wagels T; Kiss A; Bregenzer T; Vernazza P; Jäger H; Spirig R; Battegay M;
    Infection; 2005 Aug; 33(4):249-56. PubMed ID: 16091895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy.
    O'Brien DP; Sauvageot D; Zachariah R; Humblet P;
    AIDS; 2006 Oct; 20(15):1955-60. PubMed ID: 16988517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible posterior leukoencephalopathy syndrome in 2 HIV-infected patients receiving antiretroviral therapy.
    Ridolfo AL; Resta F; Milazzo L; Caramma I; Matacena G; Antinori S; Galli M
    Clin Infect Dis; 2008 Jan; 46(2):e19-22. PubMed ID: 18171242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study.
    Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U;
    Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients.
    Kiertiburanakul S; Khongnorasat S; Rattanasiri S; Sungkanuparph S
    J Med Assoc Thai; 2007 Feb; 90(2):237-43. PubMed ID: 17375626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya.
    Zachariah R; Van Engelgem I; Massaquoi M; Kocholla L; Manzi M; Suleh A; Phillips M; Borgdorff M
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):288-93. PubMed ID: 18258272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of HIV testing on uptake of HIV therapy among antiretroviral naive HIV-infected injection drug users.
    Wood E; Kerr T; Hogg RS; Palepu A; Zhang R; Strathdee SA; Montaner JS
    Drug Alcohol Rev; 2006 Sep; 25(5):451-4. PubMed ID: 16939941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HIV-infection].
    Wasmuth JC; Rockstroh JK
    Dtsch Med Wochenschr; 2007 Mar; 132(13):673-83; quiz 685-6. PubMed ID: 17377882
    [No Abstract]   [Full Text] [Related]  

  • 31. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico.
    Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B
    AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting the time for CD4 T-cell count to return to nadir in the course of CD4-guided therapy interruption in chronic HIV infection.
    Boschi A; Tinelli C; Ortolani P; Arlotti M
    HIV Med; 2008 Jan; 9(1):19-26. PubMed ID: 18199169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and mid-term prognosis of acute coronary syndrome in HIV-infected patients on antiretroviral therapy.
    Boccara F; Ederhy S; Janower S; Benyounes N; Odi G; Cohen A
    HIV Med; 2005 Jul; 6(4):240-4. PubMed ID: 16011528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy.
    Mary-Krause M; Billaud E; Poizot-Martin I; Simon A; Dhiver C; Dupont C; Salmon D; Roudiere L; Costagliola D;
    AIDS; 2006 Aug; 20(12):1627-35. PubMed ID: 16868444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of an HIV-infected patient with reactive arthritis treated with infliximab.
    Gaylis NB
    J Clin Rheumatol; 2012 Apr; 18(3):153-4. PubMed ID: 22426582
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV therapy--what do we know, and when do we know it?
    Skolnik PR
    N Engl J Med; 2003 Dec; 349(24):2351-2. PubMed ID: 14668462
    [No Abstract]   [Full Text] [Related]  

  • 37. Haiti trial supports starting antiretroviral therapy earlier.
    AIDS Patient Care STDS; 2009 Jul; 23(7):577. PubMed ID: 19621995
    [No Abstract]   [Full Text] [Related]  

  • 38. [How long is the anti-retroviral therapy?].
    Martín MT; Codina C
    Farm Hosp; 2007; 31(4):197-9. PubMed ID: 18052612
    [No Abstract]   [Full Text] [Related]  

  • 39. Short-course antiretroviral therapy in primary HIV infection.
    Lehmann C; Wyen C; Fätkenheuer G
    N Engl J Med; 2013 May; 368(21):2036. PubMed ID: 23697519
    [No Abstract]   [Full Text] [Related]  

  • 40. [Encephalopathy in HIV patients on antiretroviral therapy].
    Kishida S
    Rinsho Shinkeigaku; 2015; 55(6):435-6. PubMed ID: 26103821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.